634 related articles for article (PubMed ID: 19350844)
1. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
Sauerbrei A; Wutzler P
Clin Lab; 2009; 55(1-2):1-7. PubMed ID: 19350844
[TBL] [Abstract][Full Text] [Related]
2. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
Sauerbrei A; Wutzler P
J Clin Microbiol; 2006 Sep; 44(9):3094-7. PubMed ID: 16954232
[TBL] [Abstract][Full Text] [Related]
3. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection.
Hammond O; Wang Y; Green T; Antonello J; Kuhn R; Motley C; Stump P; Rich B; Chirmule N; Marchese RD
J Med Virol; 2006 Dec; 78(12):1679-87. PubMed ID: 17063506
[TBL] [Abstract][Full Text] [Related]
4. Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.
Jenke AC; Klein S; Baiker A; Wirth S; Sander M; Noelting C; Boecher O; Vizoso-Pinto MG
Pediatr Infect Dis J; 2012 Nov; 31(11):1148-52. PubMed ID: 22863912
[TBL] [Abstract][Full Text] [Related]
5. Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection.
Chris Maple PA; Gray J; Brown K; Brown D
J Virol Methods; 2009 Apr; 157(1):90-2. PubMed ID: 19135089
[TBL] [Abstract][Full Text] [Related]
6. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test.
Sauerbrei A; Färber I; Brandstädt A; Schacke M; Wutzler P
J Virol Methods; 2004 Jul; 119(1):25-30. PubMed ID: 15109817
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma release assay: a simple method for detection of varicella-zoster virus-specific cell-mediated immunity.
Otani N; Baba K; Okuno T
J Immunol Methods; 2009 Dec; 351(1-2):71-4. PubMed ID: 19818791
[TBL] [Abstract][Full Text] [Related]
8. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
[TBL] [Abstract][Full Text] [Related]
9. Comparison of fifteen commercial assays for detecting Varicella Zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals.
Chris Maple PA; Gunn A; Sellwood J; Brown DW; Gray JJ
J Virol Methods; 2009 Feb; 155(2):143-9. PubMed ID: 18996415
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test.
Sauerbrei A; Schäfler A; Hofmann J; Schacke M; Gruhn B; Wutzler P
Clin Vaccine Immunol; 2012 Aug; 19(8):1261-8. PubMed ID: 22718131
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-linked immunosorbent assay for detection of antibodies to varicella zoster virus.
Goldberg RD; Sarov I
Isr J Med Sci; 1980 Feb; 16(2):111-7. PubMed ID: 6245042
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
[TBL] [Abstract][Full Text] [Related]
13. Novel recombinant ELISA assays for determination of type-specific IgG antibodies against HSV-1 and HSV-2.
Sauerbrei A; Wutzler P
J Virol Methods; 2007 Sep; 144(1-2):138-42. PubMed ID: 17548119
[TBL] [Abstract][Full Text] [Related]
14. [Seroepidemiology of varicella-zoster virus infection measured by the fluorescent antibody to membrane antigen test].
Liu JJ; Wang ML; Gan L; Liao WJ; Chen J
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Apr; 30(4):371-5. PubMed ID: 19731531
[TBL] [Abstract][Full Text] [Related]
15. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay.
Maple PA; Rathod P; Smit E; Gray J; Brown D; Boxall EH
J Clin Virol; 2009 Jan; 44(1):9-14. PubMed ID: 18823815
[TBL] [Abstract][Full Text] [Related]
17. A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid.
Kneitz RH; Schubert J; Tollmann F; Zens W; Hedman K; Weissbrich B
BMC Infect Dis; 2004 Sep; 4():33. PubMed ID: 15355548
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
Heininger U; Desgrandchamps D; Schaad UB
Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
[TBL] [Abstract][Full Text] [Related]
19. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
[TBL] [Abstract][Full Text] [Related]
20. Varicella immunity: persistent serologic non-response to immunization.
Katial RK; Ratto-Kim S; Sitz KV; Moriarity R; Engler RJ
Ann Allergy Asthma Immunol; 1999 May; 82(5):431-4. PubMed ID: 10353572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
